0.363
0.36 (0%)
As of Dec 20, 2024
Relmada Therapeutics, Inc. [RLMD]
Source:
Company Overview
Relmada Therapeutics, Inc. is a clinical-stage, publicly traded biotechnology company developing NCEs that potentially address areas of high unmet medical need in the treatment of depression and other CNS diseases.
Country | United States |
Headquarters | coral gables, florida |
Phone Number | (786) 629 1376 |
Industry | manufacturing |
CEO | Sergio Traversa |
Website | www.relmada.com |